Medical Device Industry News

FLASH: FDA panel narrowly OKs Cohera Medical's TissuGlu

August 1, 2014 by Brad Perriello

An FDA advisory panel narrowly recommends approval for Cohera Medical's TissuGlu surgical adhesive.

FLASH: FDA panel narrowly OKs Cohera Medical's TissuGlu

MassDevice.com +3 | The top 3 medtech stories for August 1, 2014

August 1, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Becton, Dickinson falls after Q3 results

August 1, 2014 by Brad Perriello

Shares of Becton, Dickinson & Co. fall after the healthcare company meets expectations with its fiscal 3rd-quarter earnings and stands pat on its outlook for the rest of the year.

Becton, Dickinson falls on Q3 results

Stryker closes portion of $375M Small Bone Innovations buy

August 1, 2014 by Brad Perriello

Stryker Corp. says it's closed the $375 million acquisition of Small Bone Innovations' assets in North America, with a 2nd closing expected 'later this year.'

Stryker closes portion of $375M Small Bone Innovations buy

Hansen Medical doubles Q2 sales, draws $23M from warrants

August 1, 2014 by Brad Perriello

Hansen Medical says it more than doubled sales of it robot-assisted surgery systems during the 2nd quarter and exercised warrants worth some $23 million.

Hansen Medical doubles Q2 sales, draws $23M from warrants

Medtronic launches new sinus dilation balloon

August 1, 2014 by Brad Perriello

Medtronic announces the launch of its NuVent EM device, a sinus dilation balloon designed to work with its Fusion ENT platform.

Medtronic launches new sinus dilation balloon

Medtronic (NYSE:MDT) said today that it's launching a new sinus dilation system to go with its Fusion ENT navigation device.

Smith & Nephew CEO: We've been an M&A target for 10 years

August 1, 2014 by Brad Perriello

Smith & Nephew CEO Olivier Bohuon says the company is under no pressure to be acquired after at least 10 years as a prominent M&A target.

YYmeta

Smith & Nephew (FTSE:SN, NYSE:SNN) isn't in a big rush to jump on the mega-merger bandwagon, CEO Olivier Bohuon said today.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp